Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers.
Jean-François YaleAude Roborel de ClimensNaresh AggarwalTerry DexUlagamadesan VenkatesanStewart B HarrisIrene HramiakJohn StewartLawrence Alan LeiterPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)
ClinicalTrials.gov identifier, NCT03767543; Date of registration: December 6, 2018; Retrospectively registered.
Keyphrases